Tag: Emcure
Novo Nordisk India partners with Emcure Pharma to commercialize ‘Poviztra’ in...
Emcure Pharma becomes the first Indian company with exclusive rights to distribute and commercialise Poviztra®, semaglutide injection 2.4 mg, for weight loss in India
Emcure Pharma delivers strong Q1 growth across domestic & international markets
Revenue up 15.7% year-on-year with robust performance in key geographies and expanded Sanofi partnership boosting future growth prospects
Emcure Pharma, Sanofi India ink exclusive pact to expand reach of...
While Sanofi will continue to own and manufacture these brands across its plants in India and internationally, Emcure will leverage its strengths to engage healthcare professionals
Emcure Pharma registers 18% revenue growth, 30% PAT in Q3 of...
Revenue from operations at Rs 1,963 Cr, up 17.7% YoY and PAT at 156Cr, up 30.3% YoY
Emcure Pharmaceuticals inaugurates world-class R&D centre
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulation
Emcure Pharma records Rs 2,002 crore operational revenue with 20% revenue...
EBITDA margins at 20.8% with EBITDA up 26.1% YoY and 15.8% QoQ
Emcure Pharma launches Emcutix Biopharma to expand dermatology offerings
The focus will be on building a differentiated product portfolio including first-time launches designed to fulfil the unmet needs of the Indian dermatology market
Emcure Pharma’s “ACE YOUR HEART” awareness campaign enters Asia Book of...
This innovative structure symbolizes the collective commitment to combat heart diseases, reflecting contributions from more than 5,000 doctors across India
Sanofi India & Emcure Pharma announce exclusive distribution partnership to broaden...
While SIL will continue to own, import, and manufacture these brands across Sanofi’s plants in India and internationally, Emcure will leverage its strengths to engage healthcare professionals
Emcure Pharmaceuticals conferred with Merit Award at HIV Congress 2023
The Merit Award acknowledges the firm’s immense contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS